INFU - AMEX

InfuSystem Holdings, Inc.

INFU·AMEX

$9.03

+0.67%

HealthcareMedical - Instruments & Supplies

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$182.24M

EPS0.3200

P/E Ratio28.22

Earnings Date08/04/2026

100.56M

Assets

-3%

3Y+1.0%

5Y+4.0%

10Y+4.0%

43.23M

Total Liabilities

-6%

3Y-16.0%

5Y-23.0%

10Y-5.0%

57.33M

Total Equity

3Y+19.0%

5Y+41.0%

10Y+13.0%

InfuSystem Holdings, Inc. Funding & Solvency Profile

INFU · AMEX

Current Assets

Cash & Cash Equivalents3.19M

Net Receivables22.90M

Inventory5.39M

Other Current Assets4.86M

Total Current Assets36 M

Non-Current Assets

Property, Plant & Equipment7.54M

Goodwill & Intangible Assets10.58M

Long-Term Investments0.00

Other Non-Current Assets41.47M

Total Non-Current Assets49 M

Total Assets

100.56M

Financial Health Analysis

Current Ratio

1.80x

Strong liquidity. The company has adequate resources to meet short-term liabilities.

Debt-to-Equity Ratio

0.75x

Balanced capital structure with moderate leverage. Equity exceeds debt, suggesting healthy financial stability.

Working Capital

16 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

36% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

InfuSystem Holdings, Inc. Balance Sheet

INFU • AMEX

InfuSystem Holdings, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	3.2M	527K	231K	165K	186K	9.6M	2.6M	4.3M	3.5M	3.4M	818K	515K	1.1M	2.3M	799K	5M	7.8M	11.5M	4M	427.4K
Short-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.2M
Cash & Short-Term Investments	3.2M	527K	231K	165K	186K	9.6M	2.6M	4.3M	3.5M	3.4M	818K	515K	1.1M	2.3M	799K	5M	7.8M	11.5M	4M	98.6M
Net Receivables	22.9M	21.2M	19.8M	16.9M	15.4M	14.7M	12.1M	9.6M	11.3M	11.6M	12.6M	10.3M	10.7M	8.5M	7.4M	6.7M	5.5M	4.2M	6.3M	0.0
Accounts Receivables	22.9M	21.2M	19.8M	16.9M	15.4M	14.7M	12.1M	9.6M	11.3M	11.6M	12.6M	10.3M	10.7M	8.5M	7.4M	6.7M	5.5M	4.2M	6.3M	0.0
Inventory	5.4M	6.5M	6.4M	4.8M	3.9M	3M	2.9M	2.3M	1.8M	2.2M	1.9M	1.8M	1.2M	1.3M	3.2M	1.7M	925K	391K	364K	0.0
Prepaids	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	934K	750K	395K	676K	1.3M	445.4K
Other Current Assets	4.9M	4M	4.2M	2.9M	2.5M	2.4M	1.7M	1.4M	1.2M	3.6M	3.6M	2.9M	2.8M	2.7M	682K	1.9M	520K	676K	1.3M	1.3M
Total Current Assets	36.3M	32.2M	30.6M	24.8M	22.1M	29.8M	19.3M	17.5M	17.7M	20.8M	20.5M	15.5M	15.9M	14.8M	13.1M	15.3M	14.7M	16.7M	11.9M	100.3M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	7.5M	9.4M	46M	48M	48.6M	44.4M	43M	24.9M	25M	30M	30.2M	22.3M	15.3M	13.9M	15.8M	16.7M	13.5M	10.9M	13.5M	0.0
Goodwill	3.7M	3.7M	3.7M	3.7M	3.7M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.1M	56.6M	56.6M	56.5M	0.0
Intangible Assets	6.9M	6.5M	7.4M	8.4M	10.9M	11.2M	15.5M	19.9M	24.5M	31.2M	31.5M	25.1M	24.2M	25.5M	28.2M	33.3M	28.9M	30.7M	32.6M	0.0
Goodwill & Intangible Assets	10.6M	10.2M	11.2M	12.1M	14.6M	11.2M	15.5M	19.9M	24.5M	31.2M	31.5M	25.1M	24.2M	25.5M	28.2M	97.3M	85.5M	87.3M	89.1M	0.0
Long-Term Investments	0.0	44.5M	0.0	44.2M	42M	0.0	0.0	0.0	-62K	0.0	134K	1.2M	1.8M	2.4M	421K	-489K	656K	-55K	-4K	98M
Tax Assets	4.6M	7.2M	9.1M	9.6M	10M	10M	0.0	0.0	62K	12.4M	11.5M	13.8M	16.3M	17.8M	18.2M	1.1M	125K	55K	4K	0.0
Other Non-Current Assets	41.5M	151K	6.1M	-39.4M	-39.8M	1.7M	1.5M	1.7M	1.7M	1.9M	2.5M	2.5M	3.9M	3M	590K	401K	207K	1.3M	1.9M	99,870.4B
Total Non-Current Assets	64.2M	71.4M	72.3M	74.6M	75.5M	67.2M	59.9M	46.5M	51.2M	75.6M	75.9M	64.8M	61.5M	62.7M	63.2M	115.1M	100M	99.5M	104.5M	99,870.5B
Other Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-99,870.5B
Total Assets	100.6M	103.6M	102.9M	99.4M	97.6M	97M	79.2M	64.1M	68.9M	96.3M	96.4M	80.2M	77.4M	77.5M	76.3M	130.4M	114.7M	116.2M	116.4M	100.3M
LIABILITIES
CURRENT LIABILITIES
Total Payables	10.8M	9.8M	8M	8.3M	7.9M	6.8M	8M	7.1M	5.5M	5.3M	6.6M	5.2M	4.7M	2.1M	4.1M	2M	1.3M	1.1M	2.3M	353.3K
Accounts Payable	10.8M	9.8M	8M	8.3M	7.9M	6.8M	8M	7.1M	5.5M	5.3M	6.6M	5.2M	4.7M	2.1M	4.1M	2M	1.3M	1M	1.1M	353.3K
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110K	2.4M	0.0
Accrued Expenses	0.0	0.0	0.0	3.3M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6M	1.6M	0.0	0.0	598K
Short Term Debt	0.0	0.0	0.0	0.0	349K	9.4M	8.1M	4.9M	3.5M	5.3M	1.8M	4.2M	4.1M	2.4M	6.6M	5.6M	5.5M	8.6M	2M	0.0
Capital Lease Obligations (Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33K	505K	2.9M	3.2M	2.2M	1.1M	1.6M	0.0	0.0	0.0	0.0	0.0	0.0
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2M	0.0
Deferred Revenue	0.0	0.0	0.0	9.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3M	2.3M	2M	0.0	4.6M	0.0	55K	0.0	0.0
Other Current Liabilities	9.4M	7.8M	7.7M	-6.8M	4.7M	6.8M	5.8M	2.7M	2.9M	2.9M	3.6M	810K	891K	2.1M	2.5M	183K	2.7M	3.5M	13.1M	14.6M
Total Current Liabilities	20.2M	17.7M	15.7M	14.5M	12.9M	23M	21.8M	14.8M	12.5M	16.4M	15.3M	14.7M	13M	10.2M	13.1M	12.4M	11.1M	13.2M	17.4M	15.5M
NON-CURRENT LIABILITIES
Long Term Debt	3.4M	23.9M	29.1M	33.2M	32.7M	29.4M	30.3M	28.8M	25.4M	26.6M	26.5M	16.4M	19.9M	25.9M	22.6M	26.6M	18.6M	22M	30.3M	0.0
Deferred Revenue (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-6.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Deferred Tax Liabilities (Non-Current)	0.0	0.0	0.0	0.0	0.0	0.0	104K	0.0	62K	6.6M	5.2M	0.0	0.0	0.0	0.0	5.8M	3.3M	880K	4K	0.0
Other Non-Current Liabilities	19.6M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7K	66K	0.0	0.0	0.0	0.0	415K	406K	221K	0.0	0.0	19.6M
Total Non-Current Liabilities	23.1M	28.4M	34.9M	36.9M	36.4M	33.2M	35M	28.8M	25.5M	29.2M	29.9M	19M	21.6M	27.3M	23M	32.8M	22.2M	22.9M	30.3M	19.6M
Capital Lease Obligations	0.0	4.6M	5.8M	3.8M	3.7M	3.9M	4.6M	33K	538K	5.5M	6.4M	4.8M	2.7M	1.6M	0.0	0.0	0.0	0.0	0.0	0.0
Total Liabilities	43.2M	46.1M	50.6M	51.4M	49.3M	56.2M	56.9M	43.6M	37.9M	45.7M	45.2M	33.8M	34.7M	37.5M	36.1M	45.2M	33.2M	36.1M	47.7M	35.2M
SHAREHOLDERS' EQUITY
Common Stock	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2.1K
Additional Paid-In Capital	0.0	113.9M	109.8M	105.9M	101.9M	84.8M	83.7M	83.2M	92.6M	91.8M	91.2M	90.2M	89.8M	88.7M	87.5M	87M	81.4M	80.8M	79.4M	73M
Retained Earnings	-60.7M	-57.5M	-58.6M	-59.3M	-53.9M	-44M	-61.4M	-62.7M	-61.6M	-41.1M	-40M	-43.7M	-47.1M	-48.7M	-47.2M	-1.8M	53K	-721K	-10.7M	-7.9M
Accumulated Other Comprehensive Income/Loss	565K	1.1M	1.1M	1.5M	268K	0.0	0.0	-42M	-38.6M	-34.6M	-27.9M	0.0	0.0	0.0	-136K	-64K	-8.5M	-4.5M	-725K	0.0
Other Total Stockholders' Equity	117.5M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Stockholders' Equity	57.3M	57.5M	52.3M	48M	48.3M	40.8M	22.3M	20.4M	31M	50.7M	51.3M	46.5M	42.7M	40M	40.2M	85.1M	81.5M	80.1M	68.8M	65.1M
Total Equity	57.3M	57.5M	52.3M	48M	48.3M	40.8M	22.3M	20.4M	31M	50.7M	51.3M	46.5M	42.7M	40M	40.2M	85.1M	81.5M	80.1M	68.8M	65.1M
SUMMARY
Total Liabilities & Equity	100.6M	103.6M	102.9M	99.4M	97.6M	97M	79.2M	64.1M	68.9M	96.3M	96.4M	80.2M	77.4M	77.5M	76.3M	130.4M	114.7M	116.2M	116.4M	100.3M
Total Investments	0.0	44.5M	0.0	44.2M	42M	0.0	0.0	0.0	-62K	0.0	134K	1.2M	1.8M	2.4M	421K	-489K	656K	-55K	-4K	196.2M
Total Debt	3.4M	28.4M	34.9M	36.9M	36.8M	42.7M	43M	33.8M	29.4M	37.4M	34.9M	25.5M	26.7M	31.3M	29.1M	32.2M	24.1M	30.7M	32.3M	0.0
Net Debt	241K	27.9M	34.7M	36.8M	36.6M	33M	40.4M	29.5M	26M	34M	34.1M	25M	25.6M	28.9M	28.3M	27.2M	16.4M	19.2M	28.3M	-427.4K
Shares Outstanding	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183	20,336,183

SEC Filings

INFU - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	May 18, 2026	May 12, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 14, 2026	May 11, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 12, 2026	May 11, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 08, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 07, 2026	May 07, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 10, 2026	April 10, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 19, 2026	March 13, 2026	2026	View Filing
8-K 8-K 2026 N/A	March 16, 2026	March 16, 2026	2026	View Filing
8-K 8-K 2026 N/A	February 27, 2026	February 27, 2026	2026	View Filing

Showing 1 to 10 of 475 filings

Related Guides

Blog Categories

Continue your INFU research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.